Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data
Background: In 2012, WHO changed its recommendation for intermittent preventive treatment of malaria during pregnancy (IPTp) from two doses to monthly doses of sulfadoxine-pyrimethamine during the second and third trimesters, but noted the importance of a cost-effectiveness analysis to lend support...
Main Authors: | Silke Fernandes, MSc, Elisa Sicuri, PhD, Kassoum Kayentao, MD, Anne Maria van Eijk, PhD, Jenny Hill, PhD, Jayne Webster, PhD, Vincent Were, MSc, James Akazili, PhD, Mwayi Madanitsa, MD, Prof. Feiko O ter Kuile, PhD, Prof. Kara Hanson, ScD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-03-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X14703857 |
Similar Items
-
Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation
by: Prof Anna Vassall, PhD, et al.
Published: (2017-07-01) -
Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review and meta-analysis
by: Anna M van Eijk, PhD, et al.
Published: (2015-10-01) -
Health co-benefits from air pollution and mitigation costs of the Paris Agreement: a modelling study
by: Prof Anil Markandya, PhD, et al.
Published: (2018-03-01) -
Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study
by: Dr. Patrick G T Walker, PhD, et al.
Published: (2014-08-01) -
Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial
by: Bernadette Li, PhD, et al.
Published: (2018-02-01)